Skip to main content

Galantamine treatment of vascular dementia: a randomized trial

Galantamine treatment of vascular dementia: a randomized trial

CSR Summary

Not Yet Available

NCT Number

Not Available

Data Specification

Annotated CRF

Available upon data request approval

Product Info

Generic Name
Product Name
Therapeutic Area
Behaviors and Mental Disorders
% Female
% White
Product Class
Alzheimer's Disease - Cholinesterase Inhibitors
Sponsor Protocol Number
Data Partner
Johnson & Johnson
Condition Studied
Alzheimer Disease
Mean/Median Age (Years)

Supporting Documentation

Clinical Study Report
Collected Datasets
Data Definition Specification
Annotated Case Report Form
Protocol with Amendments
Statistical Analysis Plan


Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.